Tim Somervaille News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Inobrodib exhibits encouraging preclinical and early-phase clinical activity through disrupting the action of p300/CBP at regulatory elements controlling key cancer genes.Inobrodib is the first in a new class of drug with promise in relapsed refractory multiple myeloma and other haematological malignancies.Patients...

A cornerstone paper published in peer-reviewed scientific journal, Cancer Cell, has demonstrated a new way to treat specific blood cancers.

A cornerstone paper published in peer-reviewed scientific journal, Cancer Cell, has demonstrated a new way to treat specific blood cancers.

A terminal cancer patient from Wirral says she is enjoying 'a new lease of life' life thanks to a clinical trial.

Clinical trial gives terminal cancer patient new lease of life A retired primary school teacher with a matter of months to live is now enjoying life thanks to a new blood cancer drug she is taking as part of a clinical trial at The Christie NHS Foundation Trust in Manchester. Six years ago Chris (Christine) Ren...